Robert Califf (Pablo Martinez Monsivais, AP Images)
FDA commish nominee's financial disclosures reveal a vast web of industry ties. Will they matter?
President Biden’s nominee to run the FDA was hit with some tepid criticism back in 2016 for being too cozy with the biopharma industry because …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
